Asensus Announces Additional Senhance Surgical System Sale

December 8, 2022

https://www.globenewswire.com/news-release/2022/12/08/2570060/0/en/Asensus-Announces-Additional-Senhance-Surgical-System-Sale.html

RESEARCH TRIANGLE PARK, N.C., Dec. 08, 2022 (GLOBE NEWSWIRE) — Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that a Senhance® Surgical System has been sold to the Company’s distribution partner in Germany focused on Eastern Europe and the Commonwealth of Independent States (CIS) region. The Senhance System will be placed at an end user oncology focused hospital.

Read more at globenewswire.com

Related news for (ASXC)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.